Learn more about us:
- MilliporeSigma’s Latest Technologies Earn Industry Recognition for Accelerating Bioprocessing 4.0
- MilliporeSigma and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the ‘Facility of the Future’ a Reality
- MilliporeSigma Awards Grant to Combined Therapeutics for its Nucleic Acid Platform That, with Virotherapy, Targets Liver Cancer
- MilliporeSigma’s New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies
- MilliporeSigma Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA
- Merck KGaA, Darmstadt, Germany, Announces € 59 Million Antibody-Drug Conjugate Manufacturing Expansion
- MilliporeSigma Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant
- MilliporeSigma and 10x Genomics Launch Powerful New Option for CRISPR Research
- Merck KGaA, Darmstadt, Germany and Baylor College of Medicine Announce Collaboration to Advance a Vaccine Manufacturing Platform to Fight Covid-19
- Merck KGaA, Darmstadt, Germany Announces Boost to Commercial Viral Vector and Gene Therapy Manufacturing Capacity
Screen readers cannot read the following searchable map.
Follow this link to reach our Job Search page to search for available jobs in a more accessible format.
BE CURIOUS AND STAY CONNECTED
Enter your email and tell us a bit about yourself, and we will keep you updated about latest company news and information about career opportunities that match your interests.
Already signed-up?